Overview

Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The pilot study will investigate whether combination treatment of Finacea 15% Gel and Brimonidine 0.33% Gel could be more effective than Brimonidine 0.33% Gel monotherapy in treating both the papules/pustules and erythema associated with rosacea.
Phase:
Phase 4
Details
Lead Sponsor:
Derm Research, PLLC
Collaborator:
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Treatments:
Azelaic acid
Brimonidine Tartrate